We revealed that HNK suppresses the progression of NASH/NAFLD to HCC in mouse models by inducing the nuclear translocation of GR and subsequent induction of MIG6, a negative regulator of EGFR protein expression. The gene discussed is NR3C1; the disease is metabolic dysfunction-associated steatohepatitis.